Financhill
Sell
44

LYEL Quote, Financials, Valuation and Earnings

Last price:
$22.73
Seasonality move :
-5.66%
Day range:
$22.30 - $23.73
52-week range:
$7.65 - $45.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
82,351.11x
P/B ratio:
1.02x
Volume:
124.6K
Avg. volume:
104.5K
1-year change:
92.13%
Market cap:
$336.3M
Revenue:
$61K
EPS (TTM):
-$19.59

Earnings Data

Next earnings date for LYEL
Mar 11
2026
Most recent earnings per share
-$2.13
Missed by $2.13
(Nov 12/2025)
Consensus Estimate
--
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LYEL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -- --
03/11/2026 Q4 -- -- -- -- --
11/12/2025 Q3 -- $15K -$2.13 -- --
08/12/2025 Q2 -- $8K -$2.89 -- --
05/13/2025 Q1 -- $7K -$0.18 -- --
03/11/2025 Q4 -- $11K -$14.40 -$2.60 -$11.80
11/07/2024 Q3 -- $34K -$0.17 -- --
08/07/2024 Q2 -- $13K -$0.18 -- --
05/06/2024 Q1 -- $3K -$0.24 -$3.60 $3.36
02/28/2024 Q4 -- $13K -$0.21 -$4.10 $3.89
11/07/2023 Q3 -- $25K -$0.20 -- --
08/08/2023 Q2 -- $27K -$0.26 -- --
05/04/2023 Q1 -- $65K -$0.27 -- --
02/28/2023 Q4 -- $48.4M -$0.03 -- --
11/08/2022 Q3 -- $3K -$0.28 -- --
08/04/2022 Q2 -- $35.7M -$0.15 -- --
05/10/2022 Q1 -- $553K -$0.28 -- --
02/28/2022 Q4 -- $2.8M -$0.34 -- --
11/12/2021 Q3 -- $2.8M -$0.20 -- --
08/12/2021 Q2 -- $2.6M -$0.26 -- --
03/31/2021 Q1 -- $2.4M -$0.22 -- --
12/31/2020 Q4 -- $2.3M -$3.15 -- --
09/30/2020 Q3 -- $1.1M -$0.15 -- --
06/30/2020 Q2 -- $3.1M -$0.42 -- --
03/31/2020 Q1 -- $1.3M -$0.13 -- --

Lyell Immunopharma, Inc. Earnings Questions

  • How Much did Lyell Immunopharma, Inc. Generate in Revenue Last Quarter?

    Lyell Immunopharma, Inc. reported $15K worth of top line sales in its most recent quarter.

  • Did Lyell Immunopharma, Inc. Beat Earnings Last Quarter?

    Lyell Immunopharma, Inc. announced earnings per share of -$2.13 which represents a miss of analyst forecast a -- per share.

  • Is Lyell Immunopharma, Inc. Profitable?

    Lyell Immunopharma, Inc. reported -$2.6M that represents -$0.14 per share over the last quarter.

  • What is the Analyst Consensus for Lyell Immunopharma, Inc. EPS Next Year?

    Lyell Immunopharma, Inc.'s earnings are forecast to decrease from -$26.23 per share to -$11.60 per share next year representing a decrease of -93.37%.

  • When is Lyell Immunopharma, Inc.'s Earnings Date?

    Lyell Immunopharma, Inc.'s next earnings date is March 11, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock